共 50 条
- [41] Population-Based Newborn Screening for Germline TP53 Variants: Clinical Benefits, Cost-Effectiveness, and Value of Further Research JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (05): : 722 - 731
- [44] Cost-effectiveness of screening for albuminuria using the Dutch population-based PREVEND and PREVEND-IT studies EUROPEAN JOURNAL OF PUBLIC HEALTH, 2006, 16 : 24 - 25
- [46] Cost-effectiveness of a national population-based screening program for type 2 diabetes: the Brazil experience Diabetology & Metabolic Syndrome, 7